2020 Q3 Form 10-Q Financial Statement
#000121380920000028 Filed on August 13, 2020
Income Statement
Concept | 2020 Q3 | 2020 Q2 | 2019 Q2 |
---|---|---|---|
Revenue | $416.4K | $524.3K | $390.9K |
YoY Change | -8.39% | 34.13% | 142.35% |
Cost Of Revenue | $266.9K | $624.2K | $322.2K |
YoY Change | -30.63% | 93.73% | 149.56% |
Gross Profit | $149.4K | -$99.97K | $68.65K |
YoY Change | 114.38% | -245.63% | 113.39% |
Gross Profit Margin | 35.89% | -19.07% | 17.56% |
Selling, General & Admin | $1.640M | $1.480M | $1.870M |
YoY Change | 54.72% | -20.86% | 103.26% |
% of Gross Profit | 1097.49% | 2724.12% | |
Research & Development | $986.1K | $1.116M | $818.2K |
YoY Change | 17.2% | 36.41% | 36.1% |
% of Gross Profit | 659.87% | 1191.97% | |
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $986.1K | $1.116M | $818.2K |
YoY Change | 17.2% | 36.41% | 36.1% |
Operating Profit | -$2.576M | -$2.798M | -$2.962M |
YoY Change | 32.57% | -5.52% | 63.06% |
Interest Expense | $76.81K | $146.6K | $265.7K |
YoY Change | -68.65% | -44.83% | 21.01% |
% of Operating Profit | |||
Other Income/Expense, Net | $76.81K | ||
YoY Change | |||
Pretax Income | -$2.500M | -$2.650M | -$2.700M |
YoY Change | 47.06% | -1.85% | 68.75% |
Income Tax | $0.00 | $0.00 | $0.00 |
% Of Pretax Income | |||
Net Earnings | -$2.499M | -$2.651M | -$2.696M |
YoY Change | 47.17% | -1.65% | 68.84% |
Net Earnings / Revenue | -600.32% | -505.74% | -689.68% |
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$90.98K | -$96.47K | -$100.6K |
COMMON SHARES | |||
Basic Shares Outstanding | 27.48M shares | 27.47M shares | 26.76M shares |
Diluted Shares Outstanding |
Balance Sheet
Concept | 2020 Q3 | 2020 Q2 | 2019 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $30.41M | $31.83M | $36.89M |
YoY Change | -14.24% | -13.72% | -16.78% |
Cash & Equivalents | $21.86M | $11.78M | $4.782M |
Short-Term Investments | $8.540M | $20.05M | $32.10M |
Other Short-Term Assets | $420.0K | $600.0K | $200.0K |
YoY Change | 425.0% | 200.0% | -74.68% |
Inventory | |||
Prepaid Expenses | |||
Receivables | $806.8K | $564.7K | $504.5K |
Other Receivables | $100.0K | $730.0K | $410.0K |
Total Short-Term Assets | $31.74M | $33.73M | $38.00M |
YoY Change | -12.94% | -11.25% | -16.63% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $0.00 | $0.00 | $1.520M |
YoY Change | -100.0% | -100.0% | 47.57% |
Other Assets | $5.558K | $6.116K | $51.58K |
YoY Change | -88.94% | -88.14% | -67.77% |
Total Long-Term Assets | $5.558K | $6.116K | $2.069M |
YoY Change | -99.73% | -99.7% | 73.85% |
TOTAL ASSETS | |||
Total Short-Term Assets | $31.74M | $33.73M | $38.00M |
Total Long-Term Assets | $5.558K | $6.116K | $2.069M |
Total Assets | $31.75M | $33.73M | $40.07M |
YoY Change | -17.59% | -15.82% | -14.33% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $976.8K | $1.144M | $963.3K |
YoY Change | 36.92% | 18.76% | 318.81% |
Accrued Expenses | $620.6K | $378.1K | $396.0K |
YoY Change | 32.02% | -4.52% | 108.44% |
Deferred Revenue | $153.9K | $41.38K | $90.57K |
YoY Change | 64.95% | -54.32% | |
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $1.751M | $1.638M | $1.450M |
YoY Change | 37.16% | 13.0% | 208.48% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
YoY Change | |||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.751M | $1.638M | $1.450M |
Total Long-Term Liabilities | $0.00 | $0.00 | $0.00 |
Total Liabilities | $1.750M | $1.640M | $1.450M |
YoY Change | 36.72% | 13.1% | 208.51% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$48.72M | -$46.22M | -$37.91M |
YoY Change | 22.98% | 21.9% | |
Common Stock | $39.74K | $39.74K | $39.37K |
YoY Change | 0.68% | 0.94% | |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | $18.90M | $18.90M | $18.93M |
YoY Change | 0.0% | -0.16% | |
Treasury Stock Shares | |||
Shareholders Equity | $29.99M | $32.09M | $38.62M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $31.75M | $33.73M | $40.07M |
YoY Change | -17.59% | -15.82% | -14.33% |
Cashflow Statement
Concept | 2020 Q3 | 2020 Q2 | 2019 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.499M | -$2.651M | -$2.696M |
YoY Change | 47.17% | -1.65% | 68.84% |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$1.390M | -$1.900M | -$1.430M |
YoY Change | -9.74% | 32.87% | -16.86% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | $11.45M | $8.930M | $2.090M |
YoY Change | 801.57% | 327.27% | 574.19% |
Cash From Investing Activities | $11.45M | $8.930M | $2.090M |
YoY Change | 801.57% | 327.27% | 574.19% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 0.000 | 50.00K | 150.0K |
YoY Change | -100.0% | -66.67% | |
NET CHANGE | |||
Cash From Operating Activities | -1.390M | -1.900M | -1.430M |
Cash From Investing Activities | 11.45M | 8.930M | 2.090M |
Cash From Financing Activities | 0.000 | 50.00K | 150.0K |
Net Change In Cash | 10.06M | 7.080M | 810.0K |
YoY Change | -11277.78% | 774.07% | -157.45% |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.390M | -$1.900M | -$1.430M |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001213809 | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2020-06-30 | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2020 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
140 Intracoastal Pointe Drive | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 404 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Jupiter | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2019Q2 | us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
us-gaap:ServiceMember | |
us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
us-gaap:ServiceMember | ||
us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
us-gaap:ServiceMember | ||
CY2020Q2 | us-gaap |
Type Of Revenue Extensible List
TypeOfRevenueExtensibleList
|
us-gaap:ServiceMember | |
CY2017Q2 | dyai |
Collaborative Arrangement Duration Of Agreement
CollaborativeArrangementDurationOfAgreement
|
P2Y | |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2020-06-30 | ||
dei |
Document Transition Report
DocumentTransitionReport
|
false | ||
dei |
Entity File Number
EntityFileNumber
|
000-55264 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
DYADIC INTERNATIONAL, INC. | ||
dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
DE | ||
dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
45-0486747 | ||
dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
140 Intracoastal Pointe Drive | ||
dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
Suite 404 | ||
dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Jupiter | ||
dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
FL | ||
dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
33477 | ||
dei |
City Area Code
CityAreaCode
|
561 | ||
dei |
Local Phone Number
LocalPhoneNumber
|
743-8333 | ||
dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | ||
dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | ||
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Entity Small Business
EntitySmallBusiness
|
true | ||
dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | ||
dei |
Entity Shell Company
EntityShellCompany
|
false | ||
dei |
Security12b Title
Security12bTitle
|
Common Stock, par value $0.001 per share | ||
dei |
Trading Symbol
TradingSymbol
|
DYAI | ||
dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | ||
CY2020Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
27482157 | shares |
CY2019Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
558530 | USD |
CY2020Q2 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
500616 | USD |
CY2020Q2 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
11781549 | USD |
CY2019Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
4823544 | USD |
CY2020Q2 | us-gaap |
Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
|
20053019 | USD |
CY2019Q4 | us-gaap |
Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
|
29399146 | USD |
CY2020Q2 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
226135 | USD |
CY2019Q4 | us-gaap |
Interest Receivable Current
InterestReceivableCurrent
|
329711 | USD |
CY2020Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
564672 | USD |
CY2019Q4 | us-gaap |
Income Taxes Receivable
IncomeTaxesReceivable
|
250308 | USD |
CY2020Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
599514 | USD |
CY2019Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
277999 | USD |
CY2020Q2 | us-gaap |
Assets Current
AssetsCurrent
|
33725505 | USD |
CY2019Q4 | us-gaap |
Assets Current
AssetsCurrent
|
35639238 | USD |
CY2020Q2 | us-gaap |
Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
|
0 | USD |
CY2019Q4 | us-gaap |
Held To Maturity Securities Noncurrent
HeldToMaturitySecuritiesNoncurrent
|
1511636 | USD |
CY2020Q2 | us-gaap |
Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
|
0 | USD |
CY2019Q4 | us-gaap |
Income Taxes Receivable Noncurrent
IncomeTaxesReceivableNoncurrent
|
250308 | USD |
CY2020Q2 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
6116 | USD |
CY2019Q4 | us-gaap |
Other Assets Noncurrent
OtherAssetsNoncurrent
|
51314 | USD |
CY2020Q2 | us-gaap |
Assets
Assets
|
33731621 | USD |
CY2019Q4 | us-gaap |
Assets
Assets
|
37452496 | USD |
CY2020Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1143961 | USD |
CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
943378 | USD |
CY2020Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
378124 | USD |
CY2019Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
566003 | USD |
CY2020Q2 | us-gaap |
Provision For Loss On Contracts
ProvisionForLossOnContracts
|
74955 | USD |
CY2019Q4 | us-gaap |
Provision For Loss On Contracts
ProvisionForLossOnContracts
|
0 | USD |
CY2020Q2 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
41376 | USD |
CY2019Q4 | us-gaap |
Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
|
78644 | USD |
CY2020Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1638416 | USD |
CY2019Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
1588025 | USD |
CY2020Q2 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2019Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
USD | |
CY2020Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2019Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2019Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2020Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
5000000 | shares |
CY2019Q4 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2020Q2 | us-gaap |
Preferred Stock Shares Issued
PreferredStockSharesIssued
|
0 | shares |
CY2019Q4 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2020Q2 | us-gaap |
Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
|
0 | shares |
CY2020Q2 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2019Q4 | us-gaap |
Preferred Stock Value
PreferredStockValue
|
0 | USD |
CY2019Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2020Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2019Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2020Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
100000000 | shares |
CY2020Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
39735659 | shares |
CY2019Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
39612659 | shares |
CY2020Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
27482157 | shares |
CY2019Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
27359157 | shares |
CY2020Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
39736 | USD |
CY2019Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
39613 | USD |
CY2020Q2 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
97200023 | USD |
CY2019Q4 | us-gaap |
Additional Paid In Capital
AdditionalPaidInCapital
|
96105851 | USD |
CY2019Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
12253502 | shares |
CY2020Q2 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
12253502 | shares |
CY2020Q2 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
18929915 | USD |
CY2019Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
18929915 | USD |
CY2020Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-46216639 | USD |
CY2019Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-41351078 | USD |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
32093205 | USD |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
35864471 | USD |
CY2020Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
33731621 | USD |
CY2019Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
37452496 | USD |
CY2020Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
524271 | USD |
CY2019Q2 | us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
390874 | USD |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
839643 | USD | |
us-gaap |
Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
|
793401 | USD | |
CY2020Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
624240 | USD |
CY2019Q2 | us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
322228 | USD |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
902422 | USD | |
us-gaap |
Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
|
650131 | USD | |
CY2020Q2 | dyai |
Provision For Contract Losses
ProvisionForContractLosses
|
74955 | USD |
CY2019Q2 | dyai |
Provision For Contract Losses
ProvisionForContractLosses
|
0 | USD |
dyai |
Provision For Contract Losses
ProvisionForContractLosses
|
74955 | USD | |
dyai |
Provision For Contract Losses
ProvisionForContractLosses
|
0 | USD | |
CY2020Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1116163 | USD |
CY2019Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
818240 | USD |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1871616 | USD | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
1510610 | USD | |
CY2020Q2 | dyai |
Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
|
0 | USD |
CY2019Q2 | dyai |
Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
|
336310 | USD |
dyai |
Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
|
0 | USD | |
dyai |
Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
|
725783 | USD | |
CY2020Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1475232 | USD |
CY2019Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1870678 | USD |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3128624 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
3298745 | USD | |
CY2020Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-31690 | USD |
CY2019Q2 | us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-4932 | USD |
us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-42557 | USD | |
us-gaap |
Foreign Currency Transaction Gain Loss Realized
ForeignCurrencyTransactionGainLossRealized
|
-10966 | USD | |
CY2020Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
3322280 | USD |
CY2019Q2 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
3352388 | USD |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
6020174 | USD | |
us-gaap |
Costs And Expenses
CostsAndExpenses
|
6196235 | USD | |
CY2020Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2798009 | USD |
CY2019Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2961514 | USD |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5180531 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-5402834 | USD | |
us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-4865561 | USD | |
CY2020Q2 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
146587 | USD |
CY2019Q2 | us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
265722 | USD |
us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
314970 | USD | |
us-gaap |
Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
|
532684 | USD | |
CY2020Q2 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-2651422 | USD |
CY2019Q2 | us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-2695792 | USD |
us-gaap |
Income Loss Attributable To Parent
IncomeLossAttributableToParent
|
-4870150 | USD | |
CY2020Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
CY2019Q2 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD | |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
900 | USD | |
CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2651422 | USD |
CY2019Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2695792 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4865561 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4871050 | USD | |
CY2020Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.10 | |
CY2019Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.10 | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.18 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
-0.18 | ||
CY2020Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
27467366 | shares |
CY2019Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
26828754 | shares |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
27459415 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
26771439 | shares | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
35864471 | USD |
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
863552 | USD | |
us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
230743 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4865561 | USD | |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
32093205 | USD |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4865561 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-4871050 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
863552 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
890166 | USD | |
us-gaap |
Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
|
229919 | USD | |
us-gaap |
Investment Income Amortization Of Premium
InvestmentIncomeAmortizationOfPremium
|
90785 | USD | |
dyai |
Provision For Contract Losses
ProvisionForContractLosses
|
74955 | USD | |
dyai |
Provision For Contract Losses
ProvisionForContractLosses
|
0 | USD | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-50204 | USD | |
us-gaap |
Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
|
-10966 | USD | |
us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-103576 | USD | |
us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
105002 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
-32112 | USD | |
us-gaap |
Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
|
189246 | USD | |
us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
0 | USD | |
us-gaap |
Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
|
-506866 | USD | |
dyai |
Increase Decreasein Prepaid Researchand Development
IncreaseDecreaseinPrepaidResearchandDevelopment
|
0 | USD | |
dyai |
Increase Decreasein Prepaid Researchand Development
IncreaseDecreaseinPrepaidResearchandDevelopment
|
-154522 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
321533 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-59867 | USD | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
154484 | USD | |
us-gaap |
Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
|
665126 | USD | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-188369 | USD | |
us-gaap |
Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
|
-3535 | USD | |
us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-37268 | USD | |
us-gaap |
Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
|
-50430 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-3903929 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
-2840965 | USD | |
us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
14677156 | USD | |
us-gaap |
Payments To Acquire Held To Maturity Securities
PaymentsToAcquireHeldToMaturitySecurities
|
23571163 | USD | |
us-gaap |
Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
25305000 | USD | |
us-gaap |
Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
|
28676000 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
10627844 | USD | |
us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
5104837 | USD | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
230743 | USD | |
us-gaap |
Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
|
149180 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
230743 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
149180 | USD | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
3347 | USD | |
us-gaap |
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
-17846 | USD | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
6958005 | USD | |
us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
2395206 | USD | |
CY2019Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4823544 | USD |
CY2018Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
2386314 | USD |
CY2020Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
11781549 | USD |
CY2019Q2 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
4781520 | USD |
us-gaap |
Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
|
0 | USD | |
us-gaap |
Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
|
506866 | USD | |
CY2020Q2 | dyai |
Number Of Scientists Working Together
NumberOfScientistsWorkingTogether
|
3 | scientist |
us-gaap |
Number Of Operating Segments
NumberOfOperatingSegments
|
1 | segment | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
Use of EstimatesThe preparation of these consolidated financial statements in accordance with GAAP requires management to make estimates and judgments that affect the reported amount of assets and liabilities and related disclosure of contingent assets and liabilities at the date of our consolidated financial statements and the reported amounts of revenues and expenses during the applicable period. Actual results may differ from these estimates under different assumptions or conditions. Such differences could be material to the consolidated financial statements. | ||
us-gaap |
Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
|
Concentrations and Credit RiskThe Company’s financial instruments that are potentially subject to concentrations of credit risk consist primarily of cash and cash equivalents, investment securities, and accounts receivable. At times, the Company has cash, cash equivalents, and investment securities at financial institutions exceeding the Federal Depository Insurance Company (“FDIC”) and the Securities Investor Protection Corporation (“SIPC”) insured limit on domestic currency and the Netherlands’ FDIC counterpart for foreign currency. The Company only deals with reputable financial institutions and has not experienced any losses in such accounts. | ||
CY2020Q2 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | USD |
CY2019Q4 | us-gaap |
Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
|
0 | USD |
CY2020Q2 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
564672 | USD |
CY2019Q4 | us-gaap |
Accounts Receivable Net Current
AccountsReceivableNetCurrent
|
558530 | USD |
CY2020Q2 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
416199 | USD |
CY2019Q4 | us-gaap |
Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
|
173890 | USD |
CY2020Q2 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
166334 | USD |
CY2019Q4 | us-gaap |
Prepaid Insurance
PrepaidInsurance
|
101221 | USD |
CY2020Q2 | dyai |
Prepaid Research And Development
PrepaidResearchAndDevelopment
|
16261 | USD |
CY2019Q4 | dyai |
Prepaid Research And Development
PrepaidResearchAndDevelopment
|
0 | USD |
CY2020Q2 | us-gaap |
Prepaid Taxes
PrepaidTaxes
|
720 | USD |
CY2019Q4 | us-gaap |
Prepaid Taxes
PrepaidTaxes
|
2888 | USD |
CY2020Q2 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
599514 | USD |
CY2019Q4 | us-gaap |
Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
|
277999 | USD |
CY2020Q2 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
1143961 | USD |
CY2019Q4 | us-gaap |
Accounts Payable Current
AccountsPayableCurrent
|
943378 | USD |
CY2020Q2 | dyai |
Research And Development In Process Current
ResearchAndDevelopmentInProcessCurrent
|
1050481 | USD |
CY2019Q4 | dyai |
Research And Development In Process Current
ResearchAndDevelopmentInProcessCurrent
|
766001 | USD |
CY2020Q2 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
5903 | USD |
CY2019Q4 | us-gaap |
Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
|
26994 | USD |
CY2020Q2 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
87577 | USD |
CY2019Q4 | us-gaap |
Accounts Payable Other Current
AccountsPayableOtherCurrent
|
150383 | USD |
CY2020Q2 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
285133 | USD |
CY2019Q4 | us-gaap |
Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
|
474388 | USD |
CY2020Q2 | dyai |
Accrued Researchand Developmentin Process Current
AccruedResearchandDevelopmentinProcessCurrent
|
38711 | USD |
CY2019Q4 | dyai |
Accrued Researchand Developmentin Process Current
AccruedResearchandDevelopmentinProcessCurrent
|
69795 | USD |
CY2020Q2 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
54280 | USD |
CY2019Q4 | us-gaap |
Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
|
21820 | USD |
CY2020Q2 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
378124 | USD |
CY2019Q4 | us-gaap |
Accrued Liabilities Current
AccruedLiabilitiesCurrent
|
566003 | USD |
CY2020Q2 | dyai |
Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
|
970846 | USD |
CY2019Q2 | dyai |
Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
|
658499 | USD |
dyai |
Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
|
1584636 | USD | |
dyai |
Research And Development Expense Outside Contracted Services
ResearchAndDevelopmentExpenseOutsideContractedServices
|
1243986 | USD | |
CY2020Q2 | dyai |
Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
|
0 | USD |
CY2019Q2 | dyai |
Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
|
37451 | USD |
dyai |
Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
|
23827 | USD | |
dyai |
Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
|
49572 | USD | |
CY2019Q2 | dyai |
Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
|
336310 | USD |
dyai |
Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
|
0 | USD | |
dyai |
Research And Development Expense Contracted Services Related Party
ResearchAndDevelopmentExpenseContractedServicesRelatedParty
|
725783 | USD | |
CY2020Q2 | dyai |
Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
|
139515 | USD |
CY2019Q2 | dyai |
Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
|
122290 | USD |
dyai |
Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
|
263153 | USD | |
dyai |
Research And Development Expense Personnel Related Costs
ResearchAndDevelopmentExpensePersonnelRelatedCosts
|
217052 | USD | |
CY2020Q2 | dyai |
Research And Development Expense Facilities Overheadand Other
ResearchAndDevelopmentExpenseFacilitiesOverheadandOther
|
5802 | USD |
CY2020Q2 | dyai |
Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
|
1116163 | USD |
CY2019Q2 | dyai |
Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
|
1154550 | USD |
dyai |
Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
|
1871616 | USD | |
dyai |
Research And Development Expense Including Related Party
ResearchAndDevelopmentExpenseIncludingRelatedParty
|
2236393 | USD | |
CY2020Q2 | dyai |
Income Tax Expense Benefit Valuation Allowance Reversal
IncomeTaxExpenseBenefitValuationAllowanceReversal
|
1001233 | USD |
us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
0 | USD | |
CY2020Q2 | us-gaap |
Unrecognized Tax Benefits
UnrecognizedTaxBenefits
|
0 | USD |
CY2020Q2 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
7600000 | USD |
CY2019Q4 | us-gaap |
Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
|
7200000 | USD |
CY2019Q4 | dyai |
Deferred Tax Assets Valuation Allowance Coverage Percent
DeferredTaxAssetsValuationAllowanceCoveragePercent
|
1 | |
CY2020Q2 | dyai |
Deferred Tax Assets Valuation Allowance Coverage Percent
DeferredTaxAssetsValuationAllowanceCoveragePercent
|
1 | |
CY2020Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4650390 | shares |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4650390 | shares | |
us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4108390 | shares | |
CY2019Q2 | us-gaap |
Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
|
4108390 | shares |
CY2020Q2 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
11781549 | USD |
CY2020Q2 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
11781549 | USD |
CY2020Q2 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
31927161 | USD |
CY2020Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
96852 | USD |
CY2020Q2 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
4259 | USD |
CY2020Q2 | dyai |
Investmentsand Cash Amortized Cost
InvestmentsandCashAmortizedCost
|
31834568 | USD |
CY2019Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
4823544 | USD |
CY2019Q4 | us-gaap |
Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
|
4823544 | USD |
CY2019Q4 | dyai |
Debt Securities Heldtomaturity Accumulated Unrecognized Loss Noncurrent
DebtSecuritiesHeldtomaturityAccumulatedUnrecognizedLossNoncurrent
|
0 | USD |
CY2019Q4 | us-gaap |
Investments And Cash
InvestmentsAndCash
|
35738787 | USD |
CY2019Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
|
22452 | USD |
CY2019Q4 | us-gaap |
Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
|
17991 | USD |
CY2019Q4 | dyai |
Investmentsand Cash Amortized Cost
InvestmentsandCashAmortizedCost
|
35734326 | USD |
CY2017Q2 | dyai |
Collaborative Arrangement Paymentfor Researchand Development Agreement
CollaborativeArrangementPaymentforResearchandDevelopmentAgreement
|
1100000 | USD |
CY2017Q2 | dyai |
Collaborative Arrangement Paymentfor Researchand Development Agreement
CollaborativeArrangementPaymentforResearchandDevelopmentAgreement
|
1000000 | EUR |
CY2020Q2 | dyai |
Prepaid Research And Development
PrepaidResearchAndDevelopment
|
20000.00 | USD |
CY2019Q4 | dyai |
Prepaid Research And Development
PrepaidResearchAndDevelopment
|
0 | USD |
CY2020Q2 | dyai |
Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
|
0 | USD |
CY2019Q2 | dyai |
Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
|
300000 | USD |
dyai |
Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
|
0 | USD | |
dyai |
Researchand Development Expense Related Party
ResearchandDevelopmentExpenseRelatedParty
|
700000 | USD | |
CY2020Q2 | dyai |
Revenue From Collaborative Arrangement Recognized
RevenueFromCollaborativeArrangementRecognized
|
99260 | USD |
dyai |
Revenue From Collaborative Arrangement Recognized
RevenueFromCollaborativeArrangementRecognized
|
174632 | USD | |
CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4650390 | shares |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3860390 | shares |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
3860390 | shares |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
1.76 | |
CY2019Q4 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P5Y8M12D | |
CY2019Q4 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
13287932 | USD |
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
|
913000 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
|
5.24 | ||
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
123000 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.88 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
|
0 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
|
0 | ||
us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
|
0 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
|
0 | ||
CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
|
4650390 | shares |
CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
|
2.44 | |
CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
|
P6Y1M6D | |
CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
|
28939039 | USD |
CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
|
3250294 | shares |
CY2020Q2 | us-gaap |
Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
|
1.76 | |
CY2020Q1 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
|
P5Y | |
CY2020Q2 | us-gaap |
Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
|
22413471 | USD |
us-gaap |
Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
|
123000 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.88 | ||
CY2020Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
436614 | USD |
CY2019Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
580603 | USD |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
863552 | USD | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
890166 | USD | |
dyai |
Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock Issued
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStockIssued
|
123000 | shares | |
us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.88 | ||
CY2020Q2 | dyai |
Sharebased Compensation Arrangementby Sharebased Payment Award Options Exercisesin Period Common Stock Issued
SharebasedCompensationArrangementbySharebasedPaymentAwardOptionsExercisesinPeriodCommonStockIssued
|
397671 | shares |
CY2020Q2 | us-gaap |
Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
|
1.59 | |
CY2019Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
35864471 | USD |
CY2020Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
426939 | USD |
CY2020Q1 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
175000 | USD |
CY2020Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2214139 | USD |
CY2020Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
34252271 | USD |
CY2020Q2 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
436613 | USD |
CY2020Q2 | us-gaap |
Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
|
55743 | USD |
CY2020Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2651422 | USD |
CY2020Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
32093205 | USD |
CY2018Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
42451169 | USD |
CY2019Q1 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
309563 | USD |
CY2019Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2175258 | USD |
CY2019Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
40585474 | USD |
CY2019Q2 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
149180 | USD |
CY2019Q2 | us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
580603 | USD |
CY2019Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2695792 | USD |
CY2019Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
38619465 | USD |
CY2019Q4 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
12253502 | shares |
CY2020Q2 | us-gaap |
Treasury Stock Common Shares
TreasuryStockCommonShares
|
12253502 | shares |
CY2019Q4 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
18900000 | USD |
CY2020Q2 | us-gaap |
Treasury Stock Value
TreasuryStockValue
|
18900000 | USD |